![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1206, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MHRA receives further ADR reports with varenicline
Reactions Weekly, Vol. 1, Iss. 1228, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MHRA receives further ADR reports with varenicline
Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Iish Medicines board received a total of 2784 ADR reports in 2011.
Reactions Weekly, Vol. 1, Iss. 1422, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Netherlands Pharmacovigilance Centre Lareb received a total of 4505 ADR reports in 2003
Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The UK MHRA has received seven reports suggesting an interaction between glucosamine and warfarin
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :